Search Results for "Urea Hand Cream 20"
Original Source: Urea [Stratus Pharamceuticals, Inc]
UREA 20% CREAM
Matching Channels
Public health is the scientific, political and sociological approach by a society to maximise the health of the population through disease preventaion and mainenance of healthy life-styles. The main...
Laxatives are medicines that relieve constipation (difficulty with bowel movements). They are a popular type of over-the-counter remedy. They can also be prescribed for conditions that could get wor...
Matching News
A Urea Based Cream for Severe Xerosis in T2DM Patients
Moisturization of foot skin in diabetics is important to prevent diabetic foot complications. This study evaluated the efficacy of a topical urea-based cream compared with a simple emollient. BMC De...
FDA Clears Drug for Urea Cycle Disorders
Glycerol phenylbutyrate has been approved for chronic management of some urea cycle disorders in patients aged 2 years and older. FDA Approvals
Ravicti OK'd for Lethal Urea Cycle Defects
(MedPage Today) -- The Food and Drug Administration has approved glycerol phenylbutyrate (Ravicti) for the treatment of the rare hereditary conditions known as urea cycle disorders.
Hyperion Therapeutics receives FDA approval for Ravicti to treat urea cycle disorders
The U.S. Food and Drug Administration today approved Ravicti (glycerol phenylbutyrate) for the chronic management of some urea cycle disorders (UCDs) in patients ages 2 years and older.
By Ann Bloom Some nutrients go hand-in-hand. Some things are just better together—like baseball and hot dogs, apple pie and ice cream, and iron and vitamin C. Yes, you read that right: iron and vita...
Polycystic kidney disease: An early urea-selective urine-concentrating defect in ADPKD
A defect in urine-concentrating ability is discernable in patients with autosomal dominant polycystic kidney disease (ADPKD) before any decline in glomerular filtration rate, and is associated with el...
Ravicti approved for urea cycle disorders
(HealthDay)—Ravicti (glycerol phenylbutyrate) has been approved by the U.S. Food and Drug Administration to treat certain urea cycle disorders (UCDs) in people 2 years and older.
FDA approves new drug for the chronic management of some urea cycle disorders
The U.S. Food and Drug Administration today approved Ravicti (glycerol phenylbutyrate) for the chronic management of some urea cycle disorders (UCDs) in patients ages 2 years and older.
Matching PubMed Articles
Background: The aims of this study were to evaluate the efficacy of Eutectic Mixture of Local Anesthetics (EMLA) cream on pain perception during scaling and to compare the intensities of pain provoked...
Background Hand eczema is a common and persistent disease with a relapsing course. Clinical data suggest that once daily treatment with corticosteroids is just as effective as twice daily treatment...
Summary Onychomycosis is a common fungal infection most often affecting the toenails. If untreated, it can cause discomfort sufficient to reduce quality of life. To evaluate efficacy and safety of...
Nasal colonization of Staphylococcus aureus (S.aureus) is known as a significant risk factor for nosocomial infections, and clearance of its nasal colonization greatly reduces the risk. In the present...
Sertaconazole 2 % cream vs. hydrocortisone 1% cream in the treatment of seborrheic dermatitis.
Abstract Objective: Seborrheic dermatitis (SD) is commonly treated with anti-inflammatory products, including topical corticosteroids. This study was undertaken to compare efficiency of sertaconazole...
